Form 4 for PMVP PMV Pharmaceuticals, Inc.
Accepted 2021-09-10 00:00:00 ET · period of report 2021-09-09 · accession 0001209191-21-055438 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-10 | 2021-09-09 | PMVP | Alland Leila | Chief Medical Off | S - Sale+OE | $30.25 | -100 | 0 | -100% | -$3,025 |
| D | 2021-09-10 | 2021-09-09 | PMVP | Alland Leila | Chief Medical Off | M - OptEx | $3.90 | +100 | 100 | New | +$390 |
| D | 2021-09-10 | 2021-09-09 | PMVP | Alland Leila | Chief Medical Off | M - OptEx | $0.00 | -100 | 353.9K | -0.0% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-09 | S | D | 100 | $30.25 | 0 | D | — | — | |
| 2 | Common | Common Stock | 2021-09-09 | M | A | 100 | $3.90 | 100 | D | — | — | |
| 3 | Derivative | Employee Stock Option (right to buy) | 2021-09-09 | M | D | 100 | $0.00 | 353,850 | D | $3.90 · — to 2030-02-04 | 100 Common Stock | (F2) One-fourth of the shares subject to the option vested on December 3, 2020, and one forty-eighth of the shares subject to the option shall vest each month thereafter. |